Study supports ability of regular aspirin use to reduce liver cancer risk
Oct 07, 2018, at 04:39 pm
New York, Oct 7 (IBNS): The results of a study led by Massachusetts General Hospital (MGH) investigators support evidence from previous studies suggesting the regular use of aspirin can reduce the risk of developing primary liver cancer – also called hepatocellular carcinoma (HCC).
Landmark study reveals: Can aspirin prolong good health?
Sep 17, 2018, at 09:10 am
Canberra, Sept 17 (IBNS): Three groundbreaking papers published in today’s New England Journal of Medicine, led by a team of Monash University researchers in Melbourne, reveal the results from a seven-year study of the benefits and risks of a low daily dose of aspirin to the lives of people over 70.